<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04727515</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU M D 186/2019</org_study_id>
    <nct_id>NCT04727515</nct_id>
  </id_info>
  <brief_title>General Anesthesia, Versus Axillary Block for Ambulatory Hand Surgery: Randomized Prospective Study</brief_title>
  <official_title>General Anesthesia, Versus Axillary Block for Ambulatory Hand Surgery: Randomized Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare between general anesthesia and axillary nerve block for ambulatory&#xD;
      hand surgery regarding postoperative sleep pattern and efficacy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Postoperative nausea and vomiting</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>Incidence of postoperative nausea and vomiting requiring treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale [VAS]</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>Visual analogue scale [VAS] will be used to measure pain score at 30 min, 1, 2, 4, 6, 8, 10, 12 and 24 h after surgery. All the study patients will be instructed about the use of the VAS scale before induction of anesthesia (VAS score 0 cm = no pain, VAS score 10 cm = worst possible pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>Pittsburgh Sleep Quality Index will be used to measure postoperative sleep disturbance. It is formed of 19 items that assess seven clinically derived domains of sleep difficulties (Sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction) over a Likert scale (0-3)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>General anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Axillary Block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive axillary nerve block</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fentanyl 2µg/kg intravenously and maintained with isoflurane</intervention_name>
    <description>Anesthesia will be induced using titration of intravenous propofol till loss of verbal contact and fentanyl 2µg/kg intravenously and maintained with isoflurane (end tidal up to 1.5%), oxygen in air 50:50 via a laryngeal mask.</description>
    <arm_group_label>General anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Axillary nerve Block</intervention_name>
    <description>Axillary block will be performed using ultrasound technique. Patients will receive an axillary block under ultrasound guidance using a linear 5-12 MHz probe.</description>
    <arm_group_label>Axillary Block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Physical Status: ASA I and II Patients after taking written and informed consent&#xD;
&#xD;
          -  Body mass index less than 30&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal of procedure or participation in the study by patients.&#xD;
&#xD;
          -  Physical status: ASA III or above&#xD;
&#xD;
          -  Subjects presenting with allergy to local anesthetics, alcohol or drug abuse.&#xD;
&#xD;
          -  Inability to cooperate mentally retarded patients.&#xD;
&#xD;
          -  Bleeding disorders.&#xD;
&#xD;
          -  Patients with preoperative obstructive sleep apnea (OSA) or any sleep disturbance.&#xD;
&#xD;
          -  Patients with body mass index more than 30.&#xD;
&#xD;
          -  Polytrauma patients or emergency operation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ain Shams University Hospitals</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 25, 2021</study_first_submitted>
  <study_first_submitted_qc>January 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2021</study_first_posted>
  <last_update_submitted>January 26, 2021</last_update_submitted>
  <last_update_submitted_qc>January 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mennatullah Mohammed</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

